| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| FOR |
| MY DNA LIFE EUROPE LTD |
| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| FOR |
| MY DNA LIFE EUROPE LTD |
| MY DNA LIFE EUROPE LTD (REGISTERED NUMBER: 10355685) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| MY DNA LIFE EUROPE LTD |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Herschel House |
| 58 Herschel Street |
| Slough |
| Berkshire |
| SL1 1PG |
| MY DNA LIFE EUROPE LTD (REGISTERED NUMBER: 10355685) |
| BALANCE SHEET |
| 31 DECEMBER 2025 |
| 31.12.25 | 31.12.24 |
| as restated |
| Notes | £ | £ |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital | 4 |
| Retained earnings | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| MY DNA LIFE EUROPE LTD (REGISTERED NUMBER: 10355685) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 1. | STATUTORY INFORMATION |
| My Dna Life Europe Ltd is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The company was dormant throughout the year ended 31 December 2025. However, reference to information relating to the period ended 31 December 2024 has been made where appropriate. |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Financial instruments |
| Basic financial instruments as covered by Section 11 of FRS102 are measured at amortised cost. The company does not have any other financial instruments as covered by Section 12 of FRS102. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was NIL (2024 - NIL). |
| 4. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.12.25 | 31.12.24 |
| value: | £ | £ |
| Ordinary | £1 | 10 | 10 |
| 5. | ULTIMATE CONTROLLING PARTY |
| The ultimate controlling party is DBG Global Enterprises Pty Ltd. |
| MY DNA LIFE EUROPE LTD (REGISTERED NUMBER: 10355685) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2025 |
| 6. | PRIOR YEAR ADJUSTMENTS |
| During the year the directors identified that the prior year financial statements included several balances which should not have been recognised. Specifically, a VAT debtor of £163 was included despite no VAT being recoverable, intercompany loan balances of £296,898 remained recorded despite having been forgiven by 31 December 2024, and a bank balance of £136 relating to an Australian group company was incorrectly included. |
| The comparative figures have been restated. The effect of the adjustment was: |
| 2024 |
| Debtors decrease | (163 | ) |
| Cash at bank decrease | (136 | ) |
| Intercompany creditors decrease | 296,898 |
| Retained earnings decrease | (296,599 | ) |
| Opening reserves at 1 January 2025 have been reduced by £296,599. |
| There is no tax impact on this adjustment. |